Normalizing the exacerbated GnRH signaling could be thus an efficient therapeutic venue for the treatment of PCOS, likely by placing women on a long-term regimen GnRH antagonist treatment throughout their reproductive lives since the effects of Cetrorelix on LH secretion are reversible after discontinuation of the treatment. Here, GNRH1 is linked to polycystic ovary syndrome.